Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biocept Inc | BIOC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4349 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4349 | 0.4349 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.32 - 13.4299 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.4349 | USD |
Biocept Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 1.14M | - | - | - | -31.46 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biocept News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/20/2023 | 05:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/16/2023 | 07:53 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/21/2023 | 07:00 | Business Wire | Enrollment Completed in the Feasibility Phase of the FORESEE.. |
| 9/08/2023 | 07:00 | Business Wire | Biocept Signs CNSide™ Licensing Agreement with Plus.. |
| 9/05/2023 | 07:00 | Business Wire | Biocept to Participate in the H.C. Wainwright Global.. |
| 8/25/2023 | 07:00 | Business Wire | Biocept to Hold Business Update Conference Call on August.. |
| 8/22/2023 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/14/2023 | 15:05 | Business Wire | Biocept Reports Second Quarter 2023 Financial Results |
| 8/14/2023 | 07:00 | Business Wire | Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two.. |
| 7/13/2023 | 17:15 | Business Wire | Biocept Announces the Passing of Board Chair M. Faye Wilson |
| 6/20/2023 | 15:15 | Business Wire | Biocept Names Antonino Morales as President and Chief.. |
| 6/14/2023 | 15:05 | Business Wire | Biocept to Present at the Maxim Group Virtual Healthcare.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIOC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 8.226 | 13.4299 | 0.32 | 1.51 | 1,257,249 | -7.79 | -94.71% |
| 3 Years | 143.40 | 155.70 | 0.32 | 46.26 | 467,012 | -142.97 | -99.70% |
| 5 Years | 27.90 | 251.40 | 0.32 | 24.77 | 3,704,958 | -27.47 | -98.44% |
Biocept Description
| Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic. |
